Evidence map›Paper›PMID 26180568›Full record

ArticleBiomicrofluidics2015

Microfluidic chip system for the selection and enrichment of cell binding aptamers.

Heidi Stoll, Heiko Kiessling, Martin Stelzle, Hans Peter Wendel, Julia Schütte, Britta Hagmeyer, Meltem Avci-Adali

Abstract read
In one paragraph

Article in Biomicrofluidics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The Application of Microfluidic Technologies in Aptamer Selection.Frontiers in cell and developmental biology · 2021
    Review
  2. Review
  3. Article
  4. INTEGRATED MICROFLUIDIC SELEX USING FREE SOLUTION ELECTROKINETICS.Journal of the Electrochemical Society · 2017
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Heidi StollDepartment of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen , Calwerstraße 7/1, 72076 Tuebingen, Germany.
Heiko KiesslingBioMEMS and Sensors Department, Natural and Medical Sciences Institute at the University of Tübingen , Markwiesenstraße 55, 72770 Reutlingen, Germany.
Martin StelzleBioMEMS and Sensors Department, Natural and Medical Sciences Institute at the University of Tübingen , Markwiesenstraße 55, 72770 Reutlingen, Germany.
Hans Peter WendelDepartment of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen , Calwerstraße 7/1, 72076 Tuebingen, Germany.
Julia SchütteBioMEMS and Sensors Department, Natural and Medical Sciences Institute at the University of Tübingen , Markwiesenstraße 55, 72770 Reutlingen, Germany.
Britta HagmeyerBioMEMS and Sensors Department, Natural and Medical Sciences Institute at the University of Tübingen , Markwiesenstraße 55, 72770 Reutlingen, Germany.
Meltem Avci-AdaliDepartment of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen , Calwerstraße 7/1, 72076 Tuebingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aptamers are promising cell targeting ligands for several applications such as for the diagnosis, therapy, and drug delivery. Especially, in the field of regenerative medicine, stem cell specific aptamers have an enormous potential. Using the combinatorial chemistry process SELEX (Systematic Evolution of Ligands by Exponential enrichment), aptamers are selected from a huge oligonucleotide library consisting of approximately 10(15) different oligonucleotides. Here, we developed a microfluidic chip system that can be used for the selection of cell specific aptamers. The major drawbacks of common cell-SELEX methods are the inefficient elimination of the unspecifically bound oligonucleotides from the cell surface and the unspecific binding/uptake of oligonucleotides by dead cells. To overcome these obstacles, a microfluidic device, which enables the simultaneous performance of dielectrophoresis and electrophoresis in the same device, was designed. Using this system, viable cells can be selectively assembled by dielectrophoresis between the electrodes and then incubated with the oligonucleotides. To reduce the rate of unspecifically bound sequences, electrophoretic fields can be applied in order to draw loosely bound oligonucleotides away from the cells. Furthermore, by increasing the flow rate in the chip during the iterative rounds of SELEX, the selection pressure can be improved and aptamers with higher affinities and specificities can be obtained. This new microfluidic device has a tremendous capability to improve the cell-SELEX procedure and to select highly specific aptamers.

Identifiers

PMID26180568
PMCPMC4474950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.